Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Hassan M, Al-Obaidi H, Karrick M, Merza N, Nawras Y, Saab O, Al-Obaidi AD, Merza F, Hashim HT, Al Zubaidi K, Al-Sabbagh D, Matbachi R, Noori Z, Amatul-Raheem H, Mansur S, Al Najafi O, Algodi M, Al Hamdany T, Kobeissy A.
Hassan M, et al. Among authors: al sabbagh d.
Gastroenterology Res. 2024 Aug;17(4):159-174. doi: 10.14740/gr1750. Epub 2024 Aug 31.
Gastroenterology Res. 2024.
PMID: 39247710
Free PMC article.